Abstract
Introduction
The tumor microenvironment (TME) in colorectal cancer (CRC) includes the gut microbiome, immune cells, angiogenic factors, and fibroblasts and plays a major role in cancer progression. The Immunoscore (IS) is based on tumor infiltration by immune cells that are known prognostic biomarkers for CRC. However, the interrelation between the IS, microbiome, and other TME factors in human CRC remains unclear.
Patients and methods
A cohort of 94 patients with CRC was examined at the Shiga University of Medical Science Hospital in Japan. The expression levels of CD3, CD8, CD31, and alpha-smooth muscle actin (α-SMA) in the primary tumor were evaluated by immunohistochemistry. The IS was calculated based on the results of the CD3 and CD8 staining assays. Microbiomes in patients with CRC were examined by amplicon sequencing.
Results
The expression levels of α-SMA and tumor-infiltrating lymphocytes in patients with CRC were negatively correlated (P = 0.006). A high IS was associated with high abundance of Lachnospiraceae in the microbiomes of patients with CRC.
Conclusion
Lymphocyte infiltration into the primary tumor was marked by reduced density of cancer-associated fibroblasts and enrichment of the Lachnospiraceae family in the gut microbiome, which may influence CRC progression.
Similar content being viewed by others
Abbreviations
- α-SMA:
-
Alpha-smooth muscle actin
- CAF:
-
Cancer-associated fibroblast
- CRC:
-
Colorectal cancer
- CT:
-
Center of tumor
- ECM:
-
Extracellular matrix
- IM:
-
Invasive margin
- LDA:
-
Linear discriminant analysis
- LEfSe:
-
Linear discriminant analysis effect size
- TIL:
-
Tumor-infiltrating lymphocyte
- TME:
-
Tumor microenvironment
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Pilleron S, Soto-Perez-de-Celis E, Vignat J, Ferlay J, Soerjomataram I, Bray F, Sarfati D (2021) Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer 148:601–608. https://doi.org/10.1002/ijc.33232
Xiong Y, Wang Y, Tiruthani K (2019) Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer. Nanomedicine 21:102034. https://doi.org/10.1016/j.nano.2019.102034
Long S, Yang Y, Shen C, Wang Y, Deng A, Qin Q, Qiao L (2020) Metaproteomics characterizes human gut microbiome function in colorectal cancer. NPJ Biofilms Microbiomes 6:14. https://doi.org/10.1038/s41522-020-0123-4
Galon J, Pages F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA (2012) The immune score as a new possible approach for the classification of cancer. J Transl Med 10:1. https://doi.org/10.1186/1479-5876-10-1
Pages F, Mlecnik B, Marliot F et al (2018) International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391:2128–2139. https://doi.org/10.1016/S0140-6736(18)30789-X
Gong J, Lin Y, Zhang H et al (2020) Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells. Cell Death Dis 11:267. https://doi.org/10.1038/s41419-020-2434-z
Freeman P, Mielgo A (2020) Cancer-associated fibroblast mediated inhibition of CD8+ Cytotoxic T cell accumulation in tumours: mechanisms and therapeutic opportunities. Cancers (Basel). https://doi.org/10.3390/cancers12092687
Jie Z, Xia H, Zhong SL et al (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8:845. https://doi.org/10.1038/s41467-017-00900-1
Tjalsma H, Boleij A, Marchesi JR, Dutilh BE (2012) A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10:575–582. https://doi.org/10.1038/nrmicro2819
Yu J, Feng Q, Wong SH et al (2017) Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66:70–78. https://doi.org/10.1136/gutjnl-2015-309800
Zeng MY, Inohara N, Nunez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10:18–26. https://doi.org/10.1038/mi.2016.75
Tilg H, Adolph TE, Gerner RR, Moschen AR (2018) The intestinal microbiota in colorectal cancer. Cancer Cell 33:954–964. https://doi.org/10.1016/j.ccell.2018.03.004
Lea D, Watson M, Skaland I, Hagland HR, Lillesand M, Gudlaugsson E, Soreide K (2021) A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment. Cancer Immunol Immunother 70:2049–2057. https://doi.org/10.1007/s00262-020-02834-y
Miyake T, Mori H, Yasukawa D et al (2021) The comparison of fecal microbiota in left-side and right-side human colorectal cancer. Eur Surg Res. https://doi.org/10.1159/000516922
Bolyen E, Rideout JR, Dillon MR et al (2019) Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37:852–857. https://doi.org/10.1038/s41587-019-0209-9
Walker AW, Martin JC, Scott P, Parkhill J, Flint HJ, Scott KP (2015) 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome 3:26. https://doi.org/10.1186/s40168-015-0087-4
Jian C, Luukkonen P, Yki-Jarvinen H, Salonen A, Korpela K (2020) Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling. PLoS ONE 15:e0227285. https://doi.org/10.1371/journal.pone.0227285
Seo SU, Kamada N, Munoz-Planillo R et al (2015) Distinct commensals induce interleukin-1beta via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity 42:744–755. https://doi.org/10.1016/j.immuni.2015.03.004
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60
Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI (2020) PICRUSt2 for prediction of metagenome functions. Nat Biotechnol 38:685–688. https://doi.org/10.1038/s41587-020-0548-6
Caspi R, Billington R, Keseler IM et al (2020) The MetaCyc database of metabolic pathways and enzymes—a 2019 update. Nucleic Acids Res 48:D445–D453. https://doi.org/10.1093/nar/gkz862
Clark RA, McCoy GA, Folkvord JM, McPherson JM (1997) TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event. J Cell Physiol 170:69–80. https://doi.org/10.1002/(SICI)1097-4652(199701)170:1%3c69::AID-JCP8%3e3.0.CO;2-J
Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean MC, Validire P, Trautmann A, Mami-Chouaib F, Donnadieu E (2012) Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest 122:899–910. https://doi.org/10.1172/JCI45817
Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ (2004) Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 84:493–501. https://doi.org/10.1038/labinvest.3700055
Harryvan TJ, Verdegaal EME, Hardwick JCH, Hawinkels L, van der Burg SH (2019) Targeting of the cancer-associated fibroblast-T-cell axis in solid malignancies. J Clin Med. https://doi.org/10.3390/jcm8111989
Tauriello DVF, Palomo-Ponce S, Stork D et al (2018) TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554:538–543. https://doi.org/10.1038/nature25492
Unterleuthner D, Neuhold P, Schwarz K et al (2020) Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis 23:159–177. https://doi.org/10.1007/s10456-019-09688-8
Yin H, Yu S, Xie Y, Dai X, Dong M, Sheng C, Hu J (2021) Cancer-associated fibroblasts-derived exosomes upregulate microRNA-135b-5p to promote colorectal cancer cell growth and angiogenesis by inhibiting thioredoxin-interacting protein. Cell Signal 84:110029. https://doi.org/10.1016/j.cellsig.2021.110029
Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L (2013) Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105:1907–1911. https://doi.org/10.1093/jnci/djt300
Geng J, Fan H, Tang X, Zhai H, Zhang Z (2013) Diversified pattern of the human colorectal cancer microbiome. Gut Pathog 5:2. https://doi.org/10.1186/1757-4749-5-2
Mira-Pascual L, Cabrera-Rubio R, Ocon S et al (2015) Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 50:167–179. https://doi.org/10.1007/s00535-014-0963-x
Meehan CJ, Beiko RG (2014) A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol Evol 6:703–713. https://doi.org/10.1093/gbe/evu050
Boutard M, Cerisy T, Nogue PY, Alberti A, Weissenbach J, Salanoubat M, Tolonen AC (2014) Functional diversity of carbohydrate-active enzymes enabling a bacterium to ferment plant biomass. PLoS Genet 10:e1004773. https://doi.org/10.1371/journal.pgen.1004773
Louis P, Young P, Holtrop G, Flint HJ (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12:304–314. https://doi.org/10.1111/j.1462-2920.2009.02066.x
Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, Flint HJ (2004) Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol 186:2099–2106. https://doi.org/10.1128/JB.186.7.2099-2106.2004
Takada T, Kurakawa T, Tsuji H, Nomoto K (2013) Fusicatenibacter saccharivorans gen. nov., sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 63:3691–3696. https://doi.org/10.1099/ijs.0.045823-0
Li Q, Cao L, Tian Y et al (2018) Butyrate suppresses the proliferation of colorectal cancer cells via targeting pyruvate kinase M2 and metabolic reprogramming. Mol Cell Proteomics 17:1531–1545. https://doi.org/10.1074/mcp.RA118.000752
Wang SY, Li JY, Xu JH, Xia ZS, Cheng D, Zhong W, Lai Y, Yu T, Chen QK (2019) Butyrate suppresses abnormal proliferation in colonic epithelial cells under diabetic state by targeting HMGB1. J Pharmacol Sci 139:266–274. https://doi.org/10.1016/j.jphs.2018.07.012
Ikuta D, Miyake T, Shimizu T, Sonoda H, Mukaisho KI, Tokuda A, Ueki T, Sugihara H, Tani M (2018) Fibrosis in metastatic lymph nodes is clinically correlated to poor prognosis in colorectal cancer. Oncotarget 9:29574–29586. https://doi.org/10.18632/oncotarget.25636
Acknowledgements
We would like to thank Editage (www.editage.jp) for English language editing.
Funding
This work was supported by JSPS KAKENHI (Grant No. JP 19K16831 and JP 19K18081).
Author information
Authors and Affiliations
Contributions
TM described and designed this study. ZH acquired and analyzed the staining data. TM performed the next-generation sequencing analysis. TM, HM and DY collected the clinical samples and data and supported the analysis. TM and ZH made the drafting of this manuscript. AN, AA, HM, MO, and MT revised this article. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Ethical standard
The study complied with the ethical standards of the Declaration of Helsinki and was approved by the Ethics Committee of Shiga University of Medical Science (No. R2018-037).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hexun, Z., Miyake, T., Maekawa, T. et al. High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in advanced colorectal cancer. Cancer Immunol Immunother 72, 315–326 (2023). https://doi.org/10.1007/s00262-022-03256-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-022-03256-8